Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000227250 | SCV000290382 | benign | Hereditary pheochromocytoma-paraganglioma | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566175 | SCV000675299 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002494655 | SCV002796838 | likely benign | Pheochromocytoma | 2021-10-27 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV002494655 | SCV004015619 | benign | Pheochromocytoma | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003919976 | SCV004744658 | benign | TMEM127-related disorder | 2019-05-10 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV004710613 | SCV005259872 | likely benign | not provided | criteria provided, single submitter | not provided |